Studies on multidrug resistant Pseudomonas aeruginosa from pediatric population with special reference to extended spectrum beta lactamase

Indian Journal of Science and Technology

Volumn 2, Issue 11, 2009, Pages 11-13

  Amutha Padmakrishnan, R ^a   Murugan, T ^b   Renuga Devi, M P ^c  

^a VELS INSTITUTE OF SCIENCE   (India)

^b UNIVERSITY OF MADRAS   (India)

^c SRM Arts and Science College Chennai   (India)

Author keywords

ESBL; India; MIC; Multidrug resistant; Pseudomonas aeruginosa

Indexed keywords

EID: 80052733745     PISSN: 09746846     EISSN: 09745645     Source Type: Journal    
DOI: 10.17485/ijst/2009/v2i11/29527     Document Type: Article

References (15)

1. Agnihotri N, Gupta V and Joshi RM (2004) Aerobic bacterial isolates from burn wound infections and their antibiogram-a five year study. Burns. 30, 241-243.
2. Castanheira M, Toleman MA and Jones RN (2004) Molecular characterization of beta-lactamase gene, blagim-I, encoding a new subclass of metallo-betalactamase. Antimicrobial Agents Chemotherapy. 48, 4564-4661.
3. Colle JG, Miles RS and Wan B (1996) Tests for the identification of bacteria. In: Mackie and Mc Cartney Practical Medical Microbiology. Eds. Collee JG, Fraser AG, Marmion BP & Simmons A. 14th ed. Edinburg: Churchill Livingstone. pp: 131-50.
4. Fridkin SK and Gaynes RP (1999) Antimicrobial resistance in intensive care units. Clinical Chest Med. 20, 303-316.
5. Gladstone P, Rajendran P and Brahmadathan KN (2005) Incidence of carbapenem resistance nonfermenting gram negative bacilli from patients with respiratory infections in the intensive care units. Indian J. Med. Microbiol. 23 (3), 189-191
6. Jarlier V, Nicolas MH and Fourneir G (1998) Extended spectrum ß-lactamases conferring transferable resistance to newer ß-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev. Infect. Dis.10, 867-878.
7. Mehta M, Punia JN and Joshi RM (2001) Antibiotic resistance in Pseudomonas aeruginosa strains isolated from various clinical specimen-a retrospective study. Indian J. Med. Microbiol. 19(4), 232.
8. Navaneeth BV, Sridaran D, Sahay D and Belwadi MR (2002) A preliminary study on metallo-beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J. Med. Res. 116, 264-267.
9. Niederman MS (2001) Impact of antibiotic resistance on clinical outcomes and the cost of care. Critical Care Med. 29, N114-N120.
10. Nordmann P and Naas T (1994) Sequence analysis of PER-1 extended spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta lactamase. Antimicro Agents Chemotheraphy. 38, 104-114.
11. Paladino JA, Sunderlin JL, Price CS and Schentag J (2002) Economic consequences of antimicrobial resistance. Surg. Infect. (Larchmont). 3, 259-267.
12. Poirel L, Weldhagen GF, De Champs C and Nordmann P (2002) A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended spectrum beta-lactamase GES-2 in South Africa. J. Antimicrobial. Chemotheraphy. 49, 561-565.
13. Poirel L, Le Thomas I, Naas T, Karim A and Nordmann P (2000) Biochemical sequence analysis of GES-1, a novel class A extended-spectrum betalactamase and the class 1 integron In52 from Klebsiella pneumonia. Antimicrob. Agents Chemotherapy. 44, 622-632.
14. Subha A and Ananthan S (2002) Extended spectrum ß-lactamase mediated resistance to third generation cephalosporins among Klebsiella pneumoniae in Chennai. Indian J. Med. Microbiol. 20, 92-95.
15. Veenu Gupta, Rama Sehgal and Arora DR (2002) Mic values of antimicrobial agents against non-fermenting gram negative bacilli. 97 (12), 458-459.